Refractive Surgery and Optive Compatibility Study

Phase 4

Completed

• Conditions: Dry Eye Syndromes
• Interventions: Drug: Optive

• Registration Number: NCT00469157
• Lead Sponsor: Innovative Medical

Brief Summary

To assess the compatibility of Optive with refractive surgery (PRK and LASIK) post-operatively.

Detailed Description

Not available

Study Timeline

• Study Start: 2007-05
• Study First Submitted: 2007-05-02
• Study First Submitted QC: 2007-05-03
• Study First Posted: 2007-05-04
• Status Verified: 2008-04
• Primary Completion: 2008-04
• Study Completion: 2008-04
• Last Update Submitted: 2008-04-16
• Last Update Posted: 2008-04-17

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 92

Inclusion Criteria

• Men and women 18 and over
• Patients undergoing refractive surgery

Exclusion Criteria

• Concurrent ocular conditions or pathology that could affect patient's ability to complete study

• Concurrent use of topical medications other than study medications

• Use of systemic medications with ocular drying sequelae:

  • Antihistamines
  • Decongestants
  • Antispasmotics
  • Antidepressants

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
1.	Optive	-

Primary Outcome Measures

Name	Time	Method
Assess compatibility	8 months

Secondary Outcome Measures

Name	Time	Method
comfort	8 months

Trial Locations

Locations (1)

TLC; 🇺🇸 Fullerton, California, United States